India Issues Draft Rules for Clinical Research Organizations

Tuesday, July 21, 2009 07:37 AM

India's drug regulator, the Central Drug Standard Control Organization (CDSCO), issued draft rules mandating the registration of clinical research organizations that conduct human studies on drugs, cosmetics and medical devices.

The guidelines, known as Schedule Y-1, require organizations to adhere to standard operating procedures to obtain a license of registration, which is valid for five years as long as the CRO adheres to stated requirements.

CDSCO is currently seeking comment on the proposed changes.

Earlier this summer, the organization implemented a new rule mandating that all clinical studies conducted in India be registered in a clinical trial registry maintained by the Indian Council of Medical Research.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs